Can patients use all dry powder inhalers equally well?

International Journal of Clinical Practice

Volumn 59, Issue SUPPL. 149, 2005, Pages 13-18

  Gustafsson, Per ^a   Taylor, A ^b   Zanen, P ^c   Chrystyn, H ^d  

^a QUEEN SILVIA CHILDREN'S HOSPITAL   (Sweden)

^b GLAXOSMITHKLINE   (United Kingdom)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

Dry powder inhalers; Ease of use; Inhaler performance; Lung deposition; Patient preference

Indexed keywords

ANTIASTHMATIC AGENT; BUDESONIDE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FLUTICASONE PROPIONATE; PLACEBO; SALBUTAMOL; BRONCHODILATING AGENT;

AGE DISTRIBUTION; ASTHMA; DISEASE CONTROL; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SAFETY; DRY POWDER; FORCED EXPIRATORY VOLUME; HUMAN; INDIVIDUALIZATION; POWDER INHALER; PRIORITY JOURNAL; REVIEW; UNSPECIFIED SIDE EFFECT; INHALATIONAL DRUG ADMINISTRATION; NEBULIZER; PATIENT SATISFACTION; POWDER;

ADMINISTRATION, INHALATION; ASTHMA; BRONCHODILATOR AGENTS; HUMANS; NEBULIZERS AND VAPORIZERS; PATIENT SATISFACTION; POWDERS;

EID: 33845385199     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1368-504X.2005.00722.x     Document Type: Review

References (33)

1. Keeley D, Rees J. New guidelines on asthma management. BMJ 1997; 314: 315-6.
2. Warren S, Taylor G, Smith J et al. Gamma scintigraphic evaluation of a novel budesonide dry powder inhaler using a validated radiolabelling technique. J Aerosol Med Depos Clear Eff Lung 2002; 15: 15-25.
3. Vidgren M, Kärkkäinen A, Karjalainen P et al. Effect of powder inhaler design on drug deposition in the respiratory tract. Int J Pharmaceutics 1988; 42: 211-6.
4. Thorsson L, Edsbacker S, Kalen A, Lofdahl C-G. Pharmacokinetics and systemic activity of fluticasone via Diskus and pMDI, and of budesonide via Turbuhaler. Br J Clin Pharmacol 2001; 52: 529-38.
5. Thorsson L, Edsbacker S. Less variability in lung deposition of budesonide via Turbuhaler than of fluticasone via Diskus/Accuhaler and pMDI in adults. Am J Respir Crit Care Med 2003; 167 (Suppl. 7): A896.
6. Taylor A, Gustafsson P. Do all dry powder inhalers show the same pharmaceutical performance? Int J Gen Pract 2005; 59 (Suppl. 149): 7-12.
7. Devadason SG, Everard ML, MacEarlan C et al. Lung deposition from the Turbuhaler in children with cystic fibrosis. Eur Respir J 1997; 10: 2023-8.
8. Wildhaber JH, Devadason SG, Wilson JM et al. Lung deposition of budesonide from turbuhaler in asthmatic children. Eur J Pediatr 1998; 157: 1017-22.
9. Weda M, Zanen P, de Boer AH et al. Equivalence testing of salbutamol dry powder inhalers: In vitro impaction results versus in vivo efficacy. Int J Pharm 2002; 249: 247-55.
10. Weda M, Zanen P, de Boer AH et al. An investigation into the predictive value of cascade impactor results for side effects of inhaled salbutamol. Int J Pharm 2004; 287: 79-87.
11. Ferguson AC, Spier S, Manjra A et al. Efficacy and safety of high-dose inhaled steroids in children with asthma: A comparison of fluticasone propionate with budesonide. J Pediatr 1999; 134: 422-7.
12. Ringdal N, Chuchalin A, Chovan L et al. Evaluation of different inhaled combination therapies (EDICT): A randomised, double-blind comparison of Seretide 50/250mcg bd Diskus vs formoterol 12 mcg bd and budesonide 800mcg bd given concurrently both via Turbuhaler in patients with moderate-to-severe asthma. Respir Med 2002; 96: 851-61.
13. Vanto T, Hämäläinen KM, Vahteristo M et al. Comparison of two budesonide dry powder inhalers in the treatment of asthma in children. J Aerosol Med 2004; 17: 15-24.
14. Moore A, Stone S. Patient preference for the Diskus over the Handihaler in patients with COPD. Am J Respir Crit Care Med 2003; 167: A96.
15. Sharma RK, Edwards K, Hallett C, Fuller RW. Perception among paediatric patients of the Diskus inhaler, a novel multidose powder inhaler for use in the treatment of asthma. Clin Drug Invest 1996; 11: 145-53.
16. Schlaeppi M, Edwards K, Fuller RW, Sharma R. Patient perception of the Diskus inhaler: A comparison with the Turbuhaler inhaler. Br J Clin Pract 1996; 50: 14-9.
17. Fletcher M, Hardy AJ, Karbal B, Walker SM. Effects of asthma training on inhaler device selection and utilisation in general practice. Eur Respir J 2004; 24 (Suppl. 48): 257s.
18. Tjwa MKT. Budesonide inhaled via Turbuhlaer: A more effective treatment for asthma than beclomethasone dipropionate via Rotahaler. Ann Allergy Asthma Immunol 1995; 75: 107-11.
19. Gunawardena KA, Pleace KJ, Clay MM, Fuller RW. Salmeterol delivered from a new multi-dose powder inhaler (Diskus/Accuhaler inhaler) or Diskhaler inhaler in adult asthmatics. Am J Respir Crit Care Med 1994; 149 (4 Part 2): A219.
20. Boulet LP, Cowie R, Johnston P et al. Comparison of Diskus inhaler, a new multidose powder inhaler, with Diskhaler inhaler for the delivery of salmeterol to asthmatic patients. J Asthma 1995; 32: 429-36.
21. Backman R, Baumgarten C, Sharma RK. Fluticasone propionate via Diskus inhaler at half the microgram dose of budesonide via Turbuhaler inhaler. Clin Drug Invest 2001; 21: 735-43.
22. Arossa W, Fasolo A, Fina P. Patient perception of the Diskus inhaler: A comparison with the Turbohaler inhaler. Eur Respir J 1998; 12 (Suppl. 28): 41s.
23. Chapman KR, Balter MS, Boulet L-P et al. Handling of the multidose powder inhalers Diskus versus Turbuhaler in elderly asthmatics. Am J Respir Crit Care Med 1996; 153 (4 Part 2): A61.
24. Luyt D, Vermeulen J, Johnson L, Gomez E. A comparison of the ease of handling of the Diskus/Accuhaler inhaler and the Turbohaler inhaler in children aged 6-12 years with asthma. J Aerosol Med Depos Clear Eff Lung 1995; 8: P144, 105.
25. Serra-Batlles J, Plaza V, Badiola C, Morejon E. Patient perception and acceptability of multidose dry powder inhalers. a randomised crossover comparison of Diskus/Accuhaler with Turbuhaler. J Aerosol Med 2002; 15: 59-64.
26. van der Palen J, Klein JJ, Schildkamp AM. Comparison of a new multidose powder inhaler (Diskus/Accuhaler) and the Turbuhaler regarding preference and ease of use. J Asthma 1998; 35: 147-52.
27. Molimard M, Raherison C, Lignot S et al. Assessment of handling of inhaler device in real life: An observational study in 3811 patients in primary care. J Aerosol Med 2003; 16: 249-54.
28. Agertoft L, Pedersen S. Importance of training for correct Turbuhaler use in preschool children. Acta Paediatrica 1998; 87: 842-7.
29. Hawksworth GM, James L, Chrystyn H. Characterisation of the inspiratory manoeuvre when asthmatics inhale through a Turbohaler pre- and post-counselling in a community pharmacy. Respir Med 2000; 94: 501-4.
30. Ferreira MB, Santos A, Clode MH, Carlos AGP. Turbutest in the training of asthmatic Turbuhaler users. Allergy 1999; 54: 375-9.
31. Steier J, Trammer T, Cloes RM, Petro W. Optical feedback training of inhalation with Autohaler and Turbuhaler in COPD patients. Lung 2003; 181: 183-92.
32. Broeders MEAC, Molema J, Hop WCJ, Folgering HTM. Inhalation profiles in asthmatics and COPD patients: Reproducibility and effect of instruction. J Aerosol Med 2003; 16: 131-41.
33. Clay MM, Huskisson SC, Jenkins MM. Ease of handling and clinical efficacy of a new multi-dose dry powder inhaler for the delivery of salmeterol in adult asthmatics. Eur Respir J 1994; 7 (Suppl. 18): 163s.